{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,3,29]],"date-time":"2024-03-29T12:10:10Z","timestamp":1711714210428},"reference-count":17,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2007,2,1]],"date-time":"2007-02-01T00:00:00Z","timestamp":1170288000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Int J Dermatology"],"published-print":{"date-parts":[[2007,2]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p><jats:bold>Objectives\u2002<\/jats:bold>Although the etiopathogenesis of Behcet's disease (BD) remains unknown, increased neutrophil functions such as chemotaxis, phagocytosis and excessive production of reactive oxygen species, including superoxide anion, may be responsible for the oxidative tissue damage observed in BD. Cytochrome P\u2010450 are a multigene family of enzymes involved in the detoxification and occasional activation of a wide variety of chemicals. Our aim was to investigate CYP2C9 and CYP2C19 polymorphisms in patients with BD.<\/jats:p><jats:p><jats:bold>Methods\u2002<\/jats:bold>Sixty\u2010two subjects with BD and 107 healthy control subjects were enrolled in the study. Polymorphisms of CYP2C9 and CYP2C19 were performed by real\u2010time PCR with a LightCycler instrument. We researched associations between CYP polymorphisms and BD.<\/jats:p><jats:p><jats:bold>Results\u2002<\/jats:bold>The frequencies of wild\u2010type and heterozygous CYP2C19*2 genotypes were 66.1% and 33.9% in the patients and 83.2% and 16.8% in the controls, respectively. There was a 2.53\u2010fold increased risk of Behcet's disease in individuals with the CYP2C19*2 heterozygous genotype (OR\u00a0=\u00a02.53; 95% CI, 1.22\u20135.25) when compared with the control group. But the CYP2C9*2, CYP2C9*3 and CYP2C19*3 gene polymorphisms were not related to an increased risk of developing BD.<\/jats:p><jats:p><jats:bold>Conclusions\u2002<\/jats:bold>We observed that patients with BD presented with a higher prevalence of the heterozygous CYP2C19*2 genotype. Hereditary deficiencies of this enzyme activity may lead to an imbalance between pro\u2010 and antioxidant systems, resulting in the formation of excessive reactive oxygen species.<\/jats:p>","DOI":"10.1111\/j.1365-4632.2007.02957.x","type":"journal-article","created":{"date-parts":[[2010,8,12]],"date-time":"2010-08-12T16:14:55Z","timestamp":1281629695000},"page":"153-156","update-policy":"http:\/\/dx.doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Cytochrome P450 polymorphisms in patients with Behcet's disease"],"prefix":"10.1111","volume":"46","author":[{"given":"Umit","family":"Tursen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lulufer","family":"Tamer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hale","family":"Api","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hatice","family":"Yildirim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kiymet","family":"Baz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guliz","family":"\u0130kizoglu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ugur","family":"Atik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2007,2]]},"reference":[{"key":"e_1_2_5_2_2","first-page":"1152","article-title":"Uber rezidivierende aphthouse durch ein virus verursachte Geschwuere am Mund, am Auge und an den Genitalien","volume":"105","author":"Beh\u00e7et H","year":"1937","journal-title":"Dermatol Monatsschr Wochenschr"},{"key":"e_1_2_5_3_2","doi-asserted-by":"publisher","DOI":"10.3349\/ymj.1997.38.6.423"},{"key":"e_1_2_5_4_2","first-page":"247","article-title":"Auto\u2010oxidative damage in Beh\u00e7et's disease\u2010endothelial cell damage following the elevated oxygen radicals generated by stimulated neutrophils","volume":"49","author":"Niwa Y","year":"1982","journal-title":"Clin Exp Immunol"},{"key":"e_1_2_5_5_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002281-199401000-00007"},{"key":"e_1_2_5_6_2","doi-asserted-by":"publisher","DOI":"10.1081\/DMR-120023681"},{"key":"e_1_2_5_7_2","doi-asserted-by":"publisher","DOI":"10.1097\/00008571-199412000-00001"},{"key":"e_1_2_5_8_2","doi-asserted-by":"publisher","DOI":"10.1177\/096120339400300608"},{"key":"e_1_2_5_9_2","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(200103)44:3<662::AID-ANR115>3.0.CO;2-P"},{"key":"e_1_2_5_10_2","doi-asserted-by":"crossref","first-page":"596","DOI":"10.47102\/annals-acadmedsg.V33N5p596","article-title":"Serum interleukin\u20102, interleukin\u20106, tumour necrosis factor\u2010alpha and nitric oxide levels in patients with Behcet's disease","volume":"33","author":"Akdeniz N","year":"2004","journal-title":"Ann Acad Med Singap"},{"key":"e_1_2_5_11_2","doi-asserted-by":"publisher","DOI":"10.1054\/jcaf.2002.127773"},{"key":"e_1_2_5_12_2","first-page":"736","article-title":"Cytochrome P450 1A1 and manganese superoxide dismutase gene polymorphisms in Behcet's disease","volume":"31","author":"Yen JH","year":"2004","journal-title":"J Rheumatol"},{"key":"e_1_2_5_13_2","first-page":"11","volume-title":"Beh\u00e7et's Disease Basic and Clinical Aspects","author":"International Study Group for Beh\u00e7et's Disease Contributors.","year":"1991"},{"key":"e_1_2_5_14_2","doi-asserted-by":"publisher","DOI":"10.1620\/tjem.197.9"},{"key":"e_1_2_5_15_2","first-page":"377","article-title":"Serum oxidant\/antioxidant status in patients with Behcet's disease","volume":"32","author":"Taysi S","year":"2002","journal-title":"Ann Clin Lab Sci"},{"key":"e_1_2_5_16_2","doi-asserted-by":"publisher","DOI":"10.1007\/s002280100365"},{"key":"e_1_2_5_17_2","first-page":"20","article-title":"Pathogenesis and therapy of Beh\u00e7et's disease","volume":"12","author":"Emmi L","year":"1997","journal-title":"Ann Ital Med Int"},{"key":"e_1_2_5_18_2","doi-asserted-by":"publisher","DOI":"10.1159\/000018029"}],"container-title":["International Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-4632.2007.02957.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-4632.2007.02957.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,29]],"date-time":"2024-03-29T11:32:23Z","timestamp":1711711943000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-4632.2007.02957.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,2]]},"references-count":17,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2007,2]]}},"alternative-id":["10.1111\/j.1365-4632.2007.02957.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-4632.2007.02957.x","archive":["Portico"],"relation":{},"ISSN":["0011-9059","1365-4632"],"issn-type":[{"value":"0011-9059","type":"print"},{"value":"1365-4632","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,2]]},"assertion":[{"value":"2007-02-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}